Gagani Athauda, MD

2003-2005 Urologic Oncology Branch National Cancer Institue-NIH 
 2006- Cellular Biology and Pharmacology Herbert Wertheim College of Medicine, Florida International University 
"Gagani Athauda"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McNeil BK, Sorbellini M, Grubb RL, et al. (2014) Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder. Journal of Translational Medicine. 12: 199
Athauda G, Cecchi F, Ito T, et al. (2012) HGF (hepatocyte growth factor (hepapoietin A; scatter factor)) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Sorbellini M, McNeil B, Cohen B, et al. (2011) Urinary Met level as a novel biomarker for urothelial carcinoma of the bladder. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 257
Peach ML, Tan N, Choyke SJ, et al. (2009) Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening. Journal of Medicinal Chemistry. 52: 943-51
Monje PV, Rendon S, Athauda G, et al. (2009) Non-antagonistic relationship between mitogenic factors and cAMP in adult Schwann cell re-differentiation. Glia. 57: 947-61
Giubellino A, Shi ZD, Jenkins LM, et al. (2008) Selectivity and mechanism of action of a growth factor receptor-bound protein 2 SRC homology 2 domain binding antagonist. Journal of Medicinal Chemistry. 51: 7459-68
Monje PV, Athauda G, Wood PM. (2008) Protein kinase A-mediated gating of neuregulin-dependent ErbB2-ErbB3 activation underlies the synergistic action of cAMP on Schwann cell proliferation. The Journal of Biological Chemistry. 283: 34087-100
Athauda G, Bottaro DP. (2008) GRB2 (Growth factor receptor-bound protein 2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Peruzzi B, Athauda G, Bottaro DP. (2006) The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 14531-6
Athauda G, Giubellino A, Coleman JA, et al. (2006) c-Met ectodomain shedding rate correlates with malignant potential. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4154-62
See more...